¥256.00
3.03%
Tokyo, Sep 29, 11:30 am JST. Closed.
ISIN
JP3442200006
Symbol
4574

Taiko Pharmaceutical Co.,ltd. Stock price

¥256.00
-7.00 2.66% 1M
-32.00 11.11% 6M
-42.00 14.09% YTD
-43.00 14.38% 1Y
-97.00 27.48% 3Y
-672.00 72.41% 5Y
-278.15 52.07% 10Y
-11.08 4.15% 20Y
Tokyo, Closing price Tue, Sep 29 2026
-8.00 3.03%
ISIN
JP3442200006
Symbol
4574

Is Taiko Pharmaceutical Co.,ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
¥13.0b
Enterprise Value
¥9.9b
Net debt
positive
Cash
¥3.2b
Shares outstanding
50.3m
Valuation (TTM | estimate)
P/E
19.3
P/S
2.0 | 2.0
EV/Sales
1.5 | 1.6
EV/FCF
28.5
P/B
1.5
Dividends
DPS
¥3.30
Yield 1Y | 5Y
1.3% | 0.1%
Growth 1Y | 5Y
100.0% | -27.9%
Payout 1Y | 3Y
18.0% | -8.3%
Increased
1 Year
Financials (TTM | estimate)
Revenue
¥6.6b | ¥6.4b
EBITDA
¥718.0m
EBIT
¥430.0m
Net Income
¥688.0m
Free Cash Flow
¥348.0m
Growth (TTM | estimate)
Revenue
13.3% | -0.4%
EBITDA
61.0%
EBIT
122.8%
Net Income
66.6%
Free Cash Flow
570.3%
Margin
Gross
52.9%
EBITDA
10.8%
EBIT
6.5%
Net
10.4%
Free Cash Flow
5.3%
Financial Health
Equity Ratio
69.4%
Return on Equity
10.8%
ROCE
4.4%
ROIC
7.1%
Debt/Equity
0.0
More
EPS
¥13.7
FCF per Share
¥6.9
Short interest
-
Employees
220
Rev per Employee
¥29.1m

Taiko Pharmaceutical Co.,ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Taiko Pharmaceutical Co.,ltd. forecast:

3x Hold
43%
4x Sell
57%

Analyst Opinions

7 Analysts have issued a Taiko Pharmaceutical Co.,ltd. forecast:

Hold
43%
Sell
57%

Financial data from Taiko Pharmaceutical Co.,ltd.

Jun '26
+/-
%
6,621 6,621
13% 13%
100%
- Direct Costs 3,122 3,122
23% 23%
47%
3,499 3,499
6% 6%
53%
- Selling and Administrative Expenses 3,070 3,070
1% 1%
46%
- Research and Development Expense - -
-
-
718 718
61% 61%
11%
- Depreciation and Amortization 288 288
14% 14%
4%
EBIT (Operating Income) EBIT 430 430
123% 123%
6%
Net Profit 688 688
67% 67%
10%

In millions JPY.

Don't miss a Thing! We will send you all news about Taiko Pharmaceutical Co.,ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Taiko Pharmaceutical Co., Ltd. engages in the manufacture and sale of general medications particularly non-prescription gastrointestinal drugs and designated quasi drugs. The company is headquartered in Osaka, Osaka-Fu and currently employs 220 full-time employees. The company went IPO on 2009-03-18. The firm is engaged in three business segments. The Pharmaceutical Product segment is engaged in the manufacturing, sales and export of gastrointestinal drugs under the name SEIROGAN, SEIROGAN TOI-A (sugar coated tablet) and PISHUT. The Infection Control segment is engaged in the planning, development and sales of infection control products, which apply proprietary technique regarding chlorine dioxide gas. The Others segment is engaged in the manufacturing and sales of bath liquid, soap and gardening pyroligneous acid.

Head office Japan
CEO Dr. Shibata
Employees 220
Website www.seirogan.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today